SCHEMBL5970029

SCHEMBL5970029

COc1ccc(CCNc2ccc(-n3c(=O)[nH]c4nc[nH]c4c3=O)cn2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 1/20 0.43
▸ RIN1 Q13671 1/20 0.43
▸ CYP3A4 P08684 2/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ CYP2C19 P33261 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ ADORA2B P29275 3/20 0.41
▸ ADORA3 P0DMS8 2/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ TP53 P04637 2/20 0.39
▸ ADORA2A P29274 3/20 0.38
▸ PDE4A P27815 2/20 0.38
▸ PDE4B Q07343 2/20 0.38
▸ PDE4C Q08493 2/20 0.38
▸ PDE4D Q08499 2/20 0.38
▸ PTGDR Q13258 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5970236 0.83 ADORA2B (0.49) HTTSMN1; SMN2ADORA2BADORA3KDM4E
SCHEMBL5971083 0.81 ATM (0.49) CYP3A4CYP1A2CYP2D6CYP2C19ADORA2B
SCHEMBL5970424 0.77 ADORA2B (0.40) ADORA2BADORA3KDM4EADORA2APDE4A
SCHEMBL5970228 0.75 ADORA2B (0.45) ADORA2BADORA3ADORA2APDE4APDE4B
SCHEMBL5970280 0.74 KMT2A (0.46) CYP3A4CYP1A2CYP2D6CYP2C19ADORA2B
SCHEMBL5970321 0.74 ADORA2A (0.47) ADORA2BADORA3ADORA2APDE4APDE4B
SCHEMBL28302920 0.72 PDE4A (0.59) ADORA2BADORA3KDM4EADORA2APDE4A
SCHEMBL5970042 0.70 ABL1 (0.43) ABL1RIN1CYP3A4CYP1A2CYP2D6
SCHEMBL5970475 0.69 ADORA2B (0.49) ABL1RIN1ADORA2BADORA3ADORA2A
SCHEMBL4575173 0.68 MAPT (0.61) ABL1RIN1CYP3A4CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1658291-A2 SUBSTITUTED 8-HETEROARYL XANTHINES Adenosine Therapeutics, LLC (US) 2006-05-24 — — EP disclosed
WO-2005021548-A2 SUBSTITUTED 8-HETEROARYL XANTHINES ADENOSINE THERAPEUTICS, LLC (US) 2005-03-10 — — WO disclosed
Send feedback